William Shrank, MD, Former Chief Medical Officer at Humana, to Join WW International, Inc. Board of Directors
03 Agosto 2023 - 5:05PM
WW International, Inc. (NASDAQ: WW), known as WeightWatchers,
announced today that William Shrank, MD, MSHS, Venture Partner of
Bio and Health at Andreessen Horowitz, and former Chief Medical
Officer at Humana, has been appointed to the WeightWatchers Board
of Directors, effective as of August 5, 2023.
"It is a pleasure to welcome Dr. Shrank to the board," said
Thilo Semmelbauer, Chairman of the Board of WeightWatchers. “Dr.
Shrank brings a wide range of healthcare experiences, including as
a practicing physician and expertise in clinical outcomes for
chronic conditions. He will further advance our thought leadership
within the Clinical landscape for consumers, health providers,
payers, and employers. WeightWatchers is evolving alongside science
to cover the entire weight health spectrum and Dr. Shrank’s
experience will help ensure we are doing so in an effective and
sustainable way.”
“I am honored to be joining the WeightWatchers board at this
transformational time. I am deeply committed to improving health
outcomes for society, and I plan to bring my experience in
integrated health systems, clinical operations, policy, and
population health to help advance the Company’s mission of being
the global leader in weight health,” said Dr. Shrank.
Dr. Shrank’s appointment follows the recent elections of Tara
Comonte, board member of Strava and former CEO and current board
member of TMRW Life Sciences, Inc., and Tracey Brown, EVP and
President of Retail and U.S. Chief Customer Officer at Walgreens
and the former CEO of the American Diabetes Association.
“With Dr. Shrank joining, alongside Tara and Tracey, our Board
now has added three experienced leaders whose perspectives on
healthcare will be invaluable,” continued Semmelbauer.
Dr. William Shrank is serving as Venture Partner, Bio and Health
at Andreessen Horowitz. Previously, Dr. Shrank served as Chief
Medical Officer for Humana, where his responsibilities included
implementing Humana’s integrated care delivery strategy, with an
emphasis on advancing the Company’s clinical capabilities and core
objective of improving the health outcomes. He led Humana’s Care
Delivery Organization, clinical operations, health equity, and the
Bold Goal population health strategy. Dr. Shrank previously held
the position of Chief Medical and Corporate Affairs Officer (July
2019-July 2021) during which time he oversaw government
affairs.
Dr. Shrank joined Humana in April 2019, having previously been
employed by the University of Pittsburgh Medical Center (UPMC)
where he served as Chief Medical Officer, Insurance Services
Division from 2016 to 2019. At UPMC, Dr. Shrank was responsible for
clinical operations, policy and quality for approximately 3.5
million members in Medicare, Medicaid, behavioral health, Managed
Long Term Social Supports and commercial lines of business. He also
developed and evaluated population health programs to further
advance the medical center’s mission as an integrated delivery and
financing system.
Previously, Dr. Shrank served as Senior Vice President, Chief
Scientific Officer, and Chief Medical Officer of Provider
Innovation at CVS Health from 2013 to 2016. Prior to joining CVS
Health, Dr. Shrank served as Director, Research and Rapid-Cycle
Evaluation Group, for the Center for Medicare and Medicaid
Innovation, part of the Centers for Medicaid and Medicare Services
(CMS) from 2011 to 2013, where he led the evaluation of all payment
and health system delivery reform programs and developed the
rapid-cycle strategy to promote continuous quality improvement.
Dr. Shrank began his career as a practicing physician with
Brigham and Women’s Hospital in Boston and as an Assistant
Professor at Harvard Medical School. His research at Harvard
focused on improving the quality of prescribing and the use of
chronic medications. He has published more than 275 papers on these
topics.
About WW International, Inc. WeightWatchers is
a human-centric technology company powered by our proven,
science-based, clinically effective weight loss and weight
management program. For six decades, we have inspired millions of
people to adopt healthy habits for real life. We combine technology
and community to help members reach and sustain their goals on our
program. To learn more about the WeightWatchers approach to healthy
living, please visit ww.com. For more information about our global
business, visit our corporate website at corporate.ww.com.
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on management's current
expectations and beliefs, as well as a number of assumptions
concerning future events. These statements are subject to risks,
uncertainties, assumptions and other important factors. Readers are
cautioned not to put undue reliance on such forward-looking
statements because actual results may vary materially from those
expressed or implied. The reports filed by the Company pursuant to
United States securities laws contain discussions of these risks
and uncertainties. The Company assumes no obligation to, and
expressly disclaims any obligation to, update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. Readers are advised to review the
Company's filings with the United States Securities and Exchange
Commission (which are available on the SEC's EDGAR database at
www.sec.gov and via the Company's website at corporate.ww.com).
For more information, contact:Investors:Corey
Kingercorey.kinger@ww.com
Media:Kelsey Merkelkelsey.merkel@ww.com
WW (NASDAQ:WW)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
WW (NASDAQ:WW)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024